輸入代號或公司名稱後按 Enter
8436

大江

-1.00 (-0.93%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
106.50525成交張數12.10本益比1.53股價淨值比5.65%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q22.212.8%9.422.4514.3%3.10%14.32%
2026Q11.9254.8%9.362.1112.8%2.65%13.57%
2025Q42.797.3%8.683.0616.4%4.06%12.03%
2025Q32.5068.9%8.492.7415.8%3.89%12.39%
2025Q22.15-10.8%7.472.3813.2%3.43%11.47%
2025Q11.2411.7%7.731.378.6%1.80%11.12%
2024Q42.6046.9%7.602.9014.9%3.63%10.44%
2024Q31.48-46.6%6.771.639.0%2.11%9.60%
2024Q22.4133.9%8.062.7113.7%3.38%12.06%
2024Q11.11-20.1%7.451.278.4%1.53%10.31%
2023Q41.77-30.3%7.732.0410.4%2.50%10.98%
2023Q32.77-6.1%8.503.2014.5%4.07%12.44%
2023Q21.808.682.0910.6%2.62%13.48%
2023Q11.395.3%6.131.648.7%2.00%9.22%
2022Q42.5449.4%6.062.9916.0%3.74%8.80%
2022Q32.95-26.8%5.223.4816.9%4.54%7.85%
2022Q2-0.75-117.9%6.30-0.88-4.8%-1.19%9.39%
2022Q11.32-59.4%11.241.559.3%2.00%17.30%
2021Q41.70-55.6%13.172.0110.5%2.52%19.80%
2021Q34.03-5.0%15.304.7219.9%5.85%24.31%
2021Q24.19-6.7%15.514.9121.0%6.08%24.89%
2021Q13.253.8%15.813.8119.6%4.96%24.80%
2020Q43.8312.0%15.694.4821.8%6.22%25.13%
2020Q34.24190.4%15.284.9422.9%7.50%26.47%
2020Q24.49-34.5%12.505.2423.8%7.87%26.32%
2020Q13.13-40.8%14.873.7220.6%5.25%26.07%
2019Q43.42-39.6%17.024.0817.5%5.90%31.36%
2019Q31.46-70.6%19.273.6117.4%5.52%39.21%
2019Q26.86135.6%22.776.2424.2%9.70%48.93%
2019Q15.28171.5%18.826.2324.1%10.20%43.21%
2018Q45.67210.5%15.486.6023.6%12.45%39.41%
2018Q34.96160.0%11.645.7723.9%13.31%33.33%
2018Q22.91106.0%8.593.3420.6%8.98%29.44%
2018Q11.9579.2%7.092.2417.5%6.34%24.74%
2017Q41.8354.1%6.232.0917.8%6.37%23.17%
2017Q31.9126.1%5.592.1819.2%7.16%22.09%
2017Q21.4128.4%5.201.6217.5%5.58%22.17%
2017Q11.0946.3%4.881.2414.7%4.36%20.85%
2016Q41.184.541.3515.2%5.02%
2016Q31.511.7320.4%6.85%